CSIMarket
 


Applied Genetic Technologies Corporation  (AGTC)
Other Ticker:  
 
 

AGTC's Net Income Growth by Quarter and Year

Applied Genetic Technologies's Net Income results by quarter and year




AGTC Net Income (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter June - -18.39 -12.14 -14.50
III Quarter March - -14.29 -14.85 -11.19
II Quarter December - -19.14 -15.46 -8.62
I Quarter September -18.41 -17.12 -15.38 -11.58
FY   -18.41 -68.94 -57.83 -45.89



AGTC Net Income first quarter 2023 Y/Y Growth Comment
Applied Genetic Technologies Corporation in the first quarter 2023 recorded net loss of $ -18.41 millions.

According to the results reported in the first quarter 2023, Applied Genetic Technologies Corporation achieved the best Net Income growth in Biotechnology & Pharmaceuticals industry. While Applied Genetic Technologies Corporation' s Net Income no change of % ranks overall at the positon no. in the first quarter 2023.




AGTC Net Income ( Y/Y Growth %) 2023
2022 2021 2020
IV Quarter June - - - -
III Quarter March - - - -
II Quarter December - - - -
I Quarter September - - - -
FY   - - - -

Financial Statements
Applied Genetic Technologies's first quarter 2023 Net Income $ -18.41 millions AGTC's Income Statement
Applied Genetic Technologies's first quarter 2022 Net Income $ -17.12 millions Quarterly AGTC's Income Statement
New: More AGTC's historic Net Income Growth >>


AGTC Net Income (Quarter on Quarter Growth %)

2023
2022 2021 2020
IV Quarter June - - - -
III Quarter March - - - -
II Quarter December - - - -
I Quarter September - - - -
FY (Year on Year)   - - - -




Net Income first quarter 2023 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

Net Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Net Income first quarter 2023 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
Net Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Net Income by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Applied Genetic Technologies's Q/Q Net Income Growth


Net Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


AGTC's I. Quarter Q/Q Net Income Comment
Current net loss of -18.41 millions by Applied Genetic Technologies Corporation look even worse compare to the -18.39 millions in the fourth quarter.

Within Biotechnology & Pharmaceuticals industry Applied Genetic Technologies Corporation achieved highest sequential Net Income growth. While Applied Genetic Technologies's Net Income growth quarter on quarter, overall rank is .


Net Income Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
Net Income Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
Net Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


AGTC's I. Quarter Q/Q Net Income Comment
Recent net loss of -18.41 millions by Applied Genetic Technologies Corporation look even less good considering the net loss -18.39 millions a quarter before.

Within Biotechnology & Pharmaceuticals industry Applied Genetic Technologies Corporation achieved highest sequential Net Income growth. While Applied Genetic Technologies's Net Income growth quarter on quarter, overall rank is .


Applied Genetic Technologies's 12 Months Net Income Growth Year on Year


Net Income TTM Growth

12 Months Ending
(Sep 30 2022)
12 Months Ending
(Jun 30 2022)
12 Months Ending
(Mar 31 2022)
12 Months Ending
(Dec 31 2021)
12 Months Ending
(Sep 30 2021)
Cumulative Net Income 12 Months Ending $ -70.23 $ -68.94 $ -62.69 $ -63.25 $ -59.57
Y / Y Net Income Growth (TTM) - - - - -
Year on Year Net Income Growth Overall Ranking # # # # #
Seqeuential Net Income Change (TTM) - - - - -
Seq. Net Income Growth (TTM) Overall Ranking # # # # #




Cumulative Net Income growth Comment
Applied Genetic Technologies Corporation' has realized cumulative trailing twelve months net loss of $ -70 millions in the Sep 30 2022 period.
The business is detiriorating as the cumulative net loss is getting bigger from $ -68.94 millions in TTM ending quarter Jun 30 2022 and $ -57.829 millions for the twelve months ending in the quarter Sep 30 2021.

Applied Genetic Technologies Corporation achieved highest trailing twelve month year on year Net Income growth. While overall Net Income growth ranking, remained unchanged compare to the previous quarter at no. .

Net Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Net Income TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

Net Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Net Income growth Comment
Applied Genetic Technologies Corporation' has realized cumulative trailing twelve months net loss of $ -70 millions in the Sep 30 2022 period.
The situation is detiriorating as the cumulative net loss is becoming larger from $ -68.94 millions in the twelve months ending a quarter before and $ -57.829 millions from the TTM period ending Sep 30 2021 Makayla Jackson mentioned.

Applied Genetic Technologies Corporation achieved highest trailing twelve month year on year Net Income growth. While overall Net Income growth ranking, remained unchanged compare to the previous quarter at no. .

Net Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Income TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

Net Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Net Income Growth
Biotechnology & Pharmaceuticals Industry Net Income Growth Trends and Statistics
Healthcare Sector Net Income Growth Statistics
Net Income Growth Trends for overall market
AGTC's Net Income Growth Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Net Income Growth
Lowest Ranking Net Income Growth
Net Income Growth for AGTC's Competitors
Net Income Growth for Applied Genetic Technologies's Suppliers
Net Income Growth for AGTC's Customers

You may also want to know
AGTC's Annual Growth Rates AGTC's Profitability Ratios AGTC's Asset Turnover Ratio AGTC's Dividend Growth
AGTC's Roe AGTC's Valuation Ratios AGTC's Financial Strength Ratios AGTC's Dividend Payout Ratio
AGTC's Roa AGTC's Inventory Turnover Ratio AGTC's Growth Rates AGTC's Dividend Comparisons



Companies with similar Net Income no change for the quarter ending Sep 30 2022 within Healthcare SectorY/Y Change %Net Income for the quarter ending Sep 30 2022
Prestige Consumer Healthcare Inc 12.06%$ 12.063 millions
Assertio Holdings inc 11.69%$ 11.694 millions
Syneos Health Inc 11.25%$ 11.255 millions
Option Care Health Inc 9.43%$ 9.435 millions
Vertex Pharmaceuticals Inc9.22%$ 9.223 millions
Becton Dickinson And Company8.75%$ 8.745 millions
Iqvia Holdings Inc 8.43%$ 8.429 millions
Mettler toledo International Inc 8.30%$ 8.301 millions
Acadia Healthcare Company Inc 7.58%$ 7.579 millions
Atrion Corporation6.79%$ 6.790 millions
Avantor Inc 6.51%$ 6.505 millions
American Oncology Network Inc 4.64%$ 4.639 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com